Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of circular RNA medicines and unprecedented lipid nanoparticle (LNP) delivery solutions for oncology and ...
Net Sales at Rs 2.40 crore in December 2024 down 78.14% from Rs. 10.97 crore in December 2023. Quarterly Net Profit at Rs.
Vertex is paying Orna $65 million upfront, in part via convertible note, according to a Jan. 7 release. Orna—which acquired ...
Money raised will pay for a handwritten Torah scroll in honor of Omer Neutra, an Israeli soldier from Plainview killed in the ...
Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex ...
GlobalData on MSN1d
Vertex and Orna sign partnership to improve efficiencies of gene therapiesOrna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...
Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of ...
MPM BioImpact, a biotechnology investment firm creating and investing in innovative companies seeking to deliver transformative therapies to patients, today announced that Brian Shuster will join the ...
Stocks like SH Kelkar and Company, Ashoka Buildcon, Vodafone Idea, Bharti Airtel, Coal India, Power Grid Corporation, Nuvoco ...
Hosted on MSN5h
It's Not Just Marvel: The Greatest Strength of Most Comics Is Also Their Most Damning WeaknessRegardless if it's Marvel or DC Comics, the superhero genre has one big problem that may not have a real solution - and ...
Both sides are accusing each other of violations as the deadline nears for Israeli troops to withdraw from Lebanon.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback